9-13 May 2012 • Barcelona, Spain - Estro-events.org

ABSTRACT SuBMISSION
abstract Format:
Call all for abstra bstraCts ts
• Topic category: choose the topic category that refers to the main subject of the abstract. The Scientific Committee
reserves the right to re-categorise the abstract.
• Presentation preference: authors should indicate the presentation preference (oral, poster or no preference). Please
note that the final decision on the presentation format rests with the Scientific Committee.
• Keywords: authors are required to provide 1 to 3 keywords (different from category).
• Title: abstract titles should be brief and reflect the content of the abstract. The title (maximum 100 characters) is
important since it focuses attention (it is the “showcase” for the presentation). Do not use capital letters in the title
except for words that are always capitalised and do not use non-standard abbreviations.
• body of the abstract: abstracts should be structured in such a way as to include (1) Purpose/Objective; (2) Material/
methods; (3) Results (4) Conclusion.
• The use of standard abbreviations is desirable. a special or unusual abbreviation must be placed (in round brackets)
after the first appearance of the word for which it stands.
• The online abstract submission procedure will not accept abstracts that exceed 2500 characters (body of the abstract,
excluding spaces).
• authors can include one data table in the body of the abstract (this is not included in the number of characters).
• authors can include one black and white image in JPg format. The maximum file size of each image should be 500
Kb. The maximum pixel size of the image is 600(w) x 800(h) pixel. Colour illustrations will appear in black and white.
• equations can be inserted in the text as images (only JPg format).
• The preferred font is Verdana 7.
ABSTRACT SELECTION PROCESS
abstracts submitted for presentation will be reviewed by an international panel of experts in the field of the subject.
abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic
chosen and innovation or usefulness. Research obviously not yet performed and results not yet obtained will be rejected.
abstracts WIll be selected For one oF the FolloWIng presentatIon Formats:
• Oral presentation: the abstract is selected for oral presentation at any of the proffered paper sessions.
• Poster discussion session: a limited number of the abstracts will be selected for poster presentation. a chairperson
will discuss selected posters with the authors and audience.
• Poster presentation: abstracts that have been selected for presentation in a poster format. The posters are grouped by topic
and are displayed throughout the meeting. Only a limited number of abstracts will be selected for poster presentation.
• e-poster: abstracts are available for viewing in electronic format in special stations available at the conference venue.
Withdrawal of an abstract: abstracts submitted for eSTRO 31 can be withdrawn until 10 February 2012. (To withdraw
your abstract you should send an email to events@estro.org). after this date, withdrawal of abstracts is no longer possible.
abstracts selected for oral / poster discussion / poster presentation should be presented at the meeting. If the
first (presenting) author cannot attend the conference, he / she should assign a replacement and inform the eSTRO
office of the replacement as soon as possible.
notification of outcome of abstract submission will be sent by email by end February 2012.
LATE-BREAKINg ABSTRACTS
ESTRO
31
2012
• The work and/or update must be novel, ground-breaking, of high significance, evidence-based and with scientific merit.
• The work and/or update must be original and not previously have been published or presented at any other scientific meeting.
• The abstract must present timely findings that were not available at the time of the deadline (16 January 2012). The
late breaking abstract deadline is not intended to be a second deadline for abstract submissions.
• a limited number of late-breaking abstracts will be accepted.
• Submissions will be accepted for oral presentation only.
• The deadline for late-breaking abstracts is 20 March 2012.
ABSTRACT TOPIC CATEgORIES
ClInIcal track
1. CnS and haematology
2. Head and neck
3. Lung
4. breast
5. gastrointestinal tumours (upper and lower gI)
6. genitourinary (prostate included)
7. gynaecological tumours
8. Sarcoma
9. Paediatrics
10. elderly
11. Palliation/supportive care/patient support
12. Stereotactic RT
13. Target and volume definition and imaging
14. Health economics
15. Other tumour sites
PhysIcs track
16. basic dosimetry and phantom and detector developments/characterisation
17. Dose measurements
18. Dose calculation
19. Treatment planning and comparisons
20. Treatment plan optimisation
21. Radiobiological modelling
22. Intrafraction motion management
23. Management of interfraction changes
24. Imaging: focus on clinical applications
25. Imaging: focus on Qa and technical aspects
26. Implementation of technology, techniques, clinical
protocols or trials
27. Radiation protection
28. Professional and educational issues
29. Others
radIobIology track
30. Molecular targeted agents and radiotherapy
31. The Dna damage response
32. genomics and proteomics
33. Tumour microenvironment, hypoxia & angiogenesis
34. normal tissue effects: pathogenesis and treatment
35. Predictive assays/prognostic factors
36. novel radiation modalities - particles, high LeT
37. Time dose fractionation
38. Signal transduction
39. Others
RTT track
40. Patient preparation, patient immobilization
and support aids
41. Treatment planning and dose calculation
42. Volume definition, treatment margins and geometric
uncertainties
43. Patient care
44. education and training
Page 24 /// FInal announcement /// eSTRO 31 eSTRO 31 /// FInal announcement /// Page 25